Bragar Eagel & Squire, P.C. Is Investigating Credit Acceptance, and Phathom and Encourages Investors to Contact the Firm
NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Credit Acceptance Corporation (NASDAQ: CACC), and Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT).
- NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Credit Acceptance Corporation (NASDAQ: CACC), and Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT).
- Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
- Additional information about each case can be found at the link provided.
- The CFPB stated Credit Acceptance violated New York usury laws on interest-rate limits and other consumers and investor-protection laws.